Literature DB >> 10703010

[Progressive multifocal leukoencephalopathy in AIDS. Overview and retrospective analysis of 17 patients].

S Happe1, N Lünenborg, C H Rickert, C Heese, D Reichelt, G Schuierer, C Schul, I W Husstedt.   

Abstract

We describe retrospectively the course of 17 AIDS patients with progressive multifocal leukoencephalopathy (PML) and give a review of their clinical symptoms and survival times. The relative frequency of PML in our cohort of AIDS patients was 2.6%. The mean of CD4-positive cells was 80.5 +/- 82.5/microliter. CD4-positive cells were > 200/microliter only in one patient and increased significantly under a combination of three antiretroviral drugs whereas, with the other patients, CD4-positive cells did not increase with a maximum of two antiretroviral drugs. The mean survival time was 6.6 (1.5-20) months and correlated positively with the number of CD4-positive cells. The diagnosis of PML can be regarded as confirmed when JC-virus DNA is detectable in cerebrospinal fluid, typical changes can be seen in MRI and typical clinical symptoms occur. No effective therapy is known to date. Single case reports on therapy with cidofovir, as in one of the cases described here, showed positive results.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10703010     DOI: 10.1007/s001150050014

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  3 in total

1.  The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS.

Authors:  M D Geschwind; R I Skolasky; W S Royal; J C McArthur
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy.

Authors:  Christoffer Kraemer; Stefan Evers; Thorsten Nolting; Gabriele Arendt; Ingo W Husstedt
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

3.  [Correlation between clinical apparatus-based differential diagnosis and neuropathological diagnosis in patients with AIDS].

Authors:  E Akova-Oztürk; S Evers; R Colak-Ekici; C Heese; C H Rickert; D Reichelt; I W Husstedt
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.